Epithelial restitution and wound healing in inflammatory bowel disease

被引:319
作者
Sturm, Andreas [2 ]
Dignass, Axel U. [1 ]
机构
[1] Med Klin 1, Markus Krankenhaus, Dept Gastroenterol Hepatol Oncol & Metab Dis, D-60431 Frankfurt, Germany
[2] Charite Univ Med Berlin, Dept Gastroenterol & Hepatol, Berlin, Germany
关键词
intestines; wound healing; inflammation; restitution;
D O I
10.3748/wjg.14.348
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Inflammatory bowel disease is characterized by a chronic inflammation of the intestinal mucosa. The mucosal epithelium of the alimentary tract constitutes a key element of the mucosal barrier to a broad spectrum of deleterious substances present within the intestinal lumen including bacterial microorganisms, various dietary factors, gastrointestinal secretory products and drugs. In addition, this mucosal barrier can be disturbed in the course of various intestinal disorders including inflammatory bowel diseases. Fortunately, the integrity of the gastrointestinal surface epithelium is rapidly reestablished even after extensive destruction. Rapid resealing of the epithelial barrier following injuries is accomplished by a process termed epithelial restitution, followed by more delayed mechanisms of epithelial wound healing including increased epithelial cell proliferation and epithelial cell differentiation. Restitution of the intestinal surface epithelium is modulated by a range of highly divergent factors among them a broad spectrum of structurally distinct regulatory peptides, variously described as growth factors or cytokines. Several regulatory peptide factors act from the basolateral site of the epithelial surface and enhance epithelial cell restitution through TGF-beta-dependent pathways. In contrast, members of the trefoil, factor family (TFF peptides) appear to stimulate epithelial restitution in conjunction with mucin glycoproteins through a TGF-beta-independent mechanism from the apical site of the intestinal epithelium. In addition, a number of other peptide molecules like extracellular matrix factors and blood clotting factors and also non-peptide molecules including phospholipids, short-chain fatty acids (SCFA), adenine nudeotides, trace elements and pharmacological agents modulate intestinal epithelial repair mechanisms. Repeated damage and injury of the intestinal surface are key features of various intestinal disorders including inflammatory bowel diseases and require constant repair of the epithelium. Enhancement of intestinal repair mechanisms by regulatory peptides or other modulatory factors may provide future approaches for the treatment of diseases that are characterized by injuries of the epithelial surface. (c) 2008 WJG. All rights reserved.
引用
收藏
页码:348 / 353
页数:6
相关论文
共 78 条
[1]
THE ROLE OF GROWTH-FACTORS IN GASTROINTESTINAL CELL-PROLIFERATION [J].
ALISON, MR ;
SARRAF, CE .
CELL BIOLOGY INTERNATIONAL, 1994, 18 (01) :1-10
[2]
Mesalamine promotes intestinal epithelial wound healing in vitro through a TGF-beta-independent mechanism [J].
Baumgart, DC ;
Vierziger, K ;
Sturm, A ;
Wiedenmann, B ;
Dignass, AU .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2005, 40 (08) :958-964
[3]
Growth factors in inflammatory bowel disease [J].
Beck, PL ;
Podolsky, DK .
INFLAMMATORY BOWEL DISEASES, 1999, 5 (01) :44-60
[4]
Modulation of specific intestinal epithelial progenitors by enteric neurons [J].
Bjerknes, M ;
Cheng, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (22) :12497-12502
[5]
IL-22 is increased in active Crohn's disease and promotes proinflammatory gene expression and intestinal epithelial cell migration [J].
Brand, S ;
Beigel, F ;
Olszak, T ;
Zitzmann, K ;
Eichhorst, ST ;
Otte, JM ;
Diepolder, H ;
Marquardt, A ;
Jagla, W ;
Popp, A ;
Leclair, S ;
Herrmann, K ;
Seiderer, J ;
Ochsenkühn, T ;
Göke, B ;
Auernhammer, CJ ;
Dambacher, J .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2006, 290 (04) :G827-G838
[6]
Brauchle M, 1996, AM J PATHOL, V149, P521
[7]
Vascular endothelial growth factor (VEGF164) ameliorates intestinal epithelial injury in vitro in IEC-18 and Caco-2 monolayers via induction of TGF-β release from epithelial cells [J].
Bulut, K ;
Pennartz, C ;
Felderbauer, P ;
Ansorge, N ;
Banasch, M ;
Schmitz, F ;
Schmidt, WE ;
Hoffmann, P .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2006, 41 (06) :687-692
[8]
ORIGIN, DIFFERENTIATION AND RENEWAL OF 4 MAIN EPITHELIAL-CELL TYPES IN MOUSE SMALL INTESTINE .3. ENTERO-ENDOCRINE CELLS [J].
CHENG, H ;
LEBLOND, CP .
AMERICAN JOURNAL OF ANATOMY, 1974, 141 (04) :503-&
[9]
Synthesis and biological evaluation of lisofylline (LSF) analogs as a potential treatment for Type 1 diabetes [J].
Cui, Peng ;
Macdonald, Timothy L. ;
Chen, Meng ;
Nadler, Jerry L. .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (13) :3401-3405
[10]
Serum bFGF and VEGF correlate respectively with bowel wall thickness and intramural blood flow in Crohn's disease [J].
Di Sabatino, A ;
Ciccocioppo, R ;
Armellini, E ;
Morera, R ;
Ricevuti, L ;
Cazzola, P ;
Fulle, I ;
Corazza, GR .
INFLAMMATORY BOWEL DISEASES, 2004, 10 (05) :573-577